Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OBCI
1901
DELISTED
Ocean Bio-Chem Inc
OBCI
| $3.03M | ﹤0.01% |
235,300
+13,600
| +6% | +$108K |
|
1902
AAR Corp
AIR
$5.77B
| $3.02M | ﹤0.01% |
72,200
+66,900
| +1,262% | +$3.12M |
|
1903
Aehr Test Systems
AEHR
$4.02B
| $3.02M | ﹤0.01% |
402,700
-364,100
| -47% | -$3.02M |
|
|
ALEX
1904
DELISTED
Alexander & Baldwin
ALEX
| $3.01M | ﹤0.01% |
167,931
+115,100
| +218% | +$2.37M |
|
1905
Chefs' Warehouse
CHEF
$4.57B
| $3.01M | ﹤0.01% |
77,500
+61,400
| +381% | +$2.16M |
|
1906
Ziff Davis
ZD
$1.92B
| $3.01M | ﹤0.01% |
40,400
-162,100
| -80% | -$13.4M |
|
1907
Seres Therapeutics
MCRB
$45M
| $3.01M | ﹤0.01% |
43,820
+19,850
| +83% | +$1.71M |
|
|
UMPQ
1908
DELISTED
Umpqua Holdings Corp
UMPQ
| $3M | ﹤0.01% |
178,756
-726,222
| -80% | -$12.6M |
|
1909
Tactile Systems Technology
TCMD
$537M
| $2.98M | ﹤0.01% |
+408,000
| New | +$5.17M |
|
1910
LyondellBasell Industries
LYB
$20.2B
| $2.96M | ﹤0.01% |
33,800
-547,100
| -94% | -$57M |
|
1911
Miller Industries
MLR
$640M
| $2.95M | ﹤0.01% |
130,200
+27,000
| +26% | +$686K |
|
1912
ProShares Short High Yield
SJB
$47.6M
| $2.95M | ﹤0.01% |
+149,300
| New | +$2.82M |
|
1913
Emergent Biosolutions
EBS
$230M
| $2.95M | ﹤0.01% |
95,000
-263,000
| -73% | -$8.98M |
|
|
CMBM
1914
DELISTED
Cambium Networks
CMBM
| $2.95M | ﹤0.01% |
201,200
-50,700
| -20% | -$799K |
|
1915
Omega Flex
OFLX
$291M
| $2.95M | ﹤0.01% |
27,380
+1,400
| +5% | +$159K |
|
1916
Pediatrix Medical
MD
$2.14B
| $2.95M | ﹤0.01% |
140,200
-185,600
| -57% | -$3.79M |
|
1917
Vanguard Dividend Appreciation ETF
VIG
$115B
| $2.95M | ﹤0.01% |
+20,536
| New | +$3.13M |
|
1918
Arch Capital
ACGL
$33.5B
| $2.94M | ﹤0.01% |
64,700
+41,000
| +173% | +$1.9M |
|
|
HI
1919
DELISTED
Hillenbrand
HI
| $2.94M | ﹤0.01% |
71,800
-103,920
| -59% | -$4.34M |
|
1920
Oppenheimer Holdings
OPY
$1.23B
| $2.94M | ﹤0.01% |
88,900
-36,500
| -29% | -$1.25M |
|
1921
State Street SPDR S&P Metals & Mining ETF
XME
$4.46B
| $2.92M | ﹤0.01% |
67,400
-34,400
| -34% | -$1.87M |
|
|
KRON
1922
DELISTED
Kronos Bio
KRON
| $2.92M | ﹤0.01% |
802,900
+612,145
| +321% | +$2.77M |
|
1923
Hooker Furnishings Corp
HOFT
$158M
| $2.92M | ﹤0.01% |
187,765
+110,900
| +144% | +$1.89M |
|
1924
Replimune Group
REPL
$1.42B
| $2.92M | ﹤0.01% |
166,953
-44,100
| -21% | -$725K |
|
1925
Northrim BanCorp
NRIM
$601M
| $2.92M | ﹤0.01% |
289,600
+2,400
| +0.8% | +$24.6K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.